1. [Pitfalls in the treatment of neuropathic pain in patients with cancer].
- Author
-
Schalkwijk A, Verhagen CA, Engels Y, Hekster YA, and Vissers KC
- Subjects
- Aged, Amines adverse effects, Amines therapeutic use, Amitriptyline adverse effects, Amitriptyline therapeutic use, Analgesics therapeutic use, Cyclohexanecarboxylic Acids adverse effects, Cyclohexanecarboxylic Acids therapeutic use, Dose-Response Relationship, Drug, Female, Gabapentin, Humans, Male, Neoplasms complications, Neuralgia etiology, gamma-Aminobutyric Acid adverse effects, gamma-Aminobutyric Acid therapeutic use, Analgesics adverse effects, Neuralgia drug therapy, Postural Balance drug effects, Sensation Disorders chemically induced
- Abstract
Three patients with cancer experienced severe side-effects after starting anti-neuropathic pain therapy. All patients, 1 woman and 2 men aged between 69 and 71, fell or had problems with balance. These side-effects diminished after reducing the doses or stopping the medication. It seems that side-effects in patients with cancer are more common and more severe than in other populations with neuropathic pain, such as patients with diabetic neuropathy or postherpetic neuralgia. There is little research into the treatment of neuropathic pain in patients with cancer. In this patient group it is advisable to monitor the patient at least once a week for an optimal treatment and to prevent severe side-effects, especially in the first weeks after starting the treatment.
- Published
- 2011